Stroke is the leading cause of permanent disability in the U.S., striking nearly 800,000 people each year. Hemorrhagic, or bleeding, stroke is particularly devastating, says Mayo Clinic neurologist and critical care expert William Freeman, M.D. "About 40 percent of hemorrhagic stroke patients die within a month, and half of the survivors have some type of impairment," he adds.
Dr. Freeman, along with stem cell biologist Abba Zubair, M.D., Ph.D., have teamed up in Mayo Clinic's Cell Therapy Laboratory in Jacksonville, Florida to begin a unique, U.S. Food and Drug Administration-approved study to see if stem cells can help hemorrhagic stroke patients heal.
The Mayo Clinic team has already had success repairing injured brain tissue with stem cells in rodents, which helped pave the way for this next phase of testing in people.
Learn more in the video below: